Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 3c; maintains guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.90, $0.03 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2 billion versus the consensus estimate of $2.01 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2025 EPS of $8.10-$8.30, versus the consensus of $8.14.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c